About iSBTc

The International Society for Biological Therapy of Cancer (iSBTc) is a 501 (c)(3) non-profit society of medical professionals. Recent advances in immunology and biology have opened up new horizons in the field of cancer therapy, with an upsurge in the integration of new biologic agents into clinical practice.

With several high-caliber scientific meetings with a focus on clinical and translational aspects of biologic approaches to cancer treatment and numerous networking opportunities unique to this organization, the International Society for Biological Therapy of Cancer has developed into the premier destination for interaction and innovation in the cancer biologics community.

The goals of iSBTc are directed towards the rapid dissemination of information in these areas to expedite the safe transfer of both basic and applied research to the clinical setting.

Core Purpose

To improve cancer patient outcomes by advancing the science, development and application of biological therapy/immunotherapy.

Core Values

Interaction/Integration - exchange of information and education among basic and translational researchers, clinicians, and young investigators; societies and groups sharing the vision and core values of iSBTc

Innovation - challenge the thinking and seek the best research in the development of biological therapy/immunotherapy

Translation - promote the application and understanding of biological therapy/immunotherapy

Leadership - define what is new and important and effectively communicate it to all relevant stakeholders